Watch for Duplicate Carbidopa/Levodopa Orders on Discharge Paperwork

Rytary (rye-TAR-ee) is a new EXTENDED-release formulation of carbidopa/levodopa for Parkinson's disease.

Think of this new carbidopa/levodopa formulation as combining the fast onset of the IMMEDIATE-release (Sinemet, etc)...with the longer duration of the SUSTAINED-release (Sinemet CR, etc).

In general, expect Rytary to be used in patients admitted with advanced Parkinson's...especially in patients who have "off" time despite taking other carbidopa/levodopa products at least 4 times daily.

Get unlimited access through an Enterprise license

Hospital Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Not sold to individuals